We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Consumer Staple Stocks to Buy With Earnings Beat Potential
Read MoreHide Full Article
Even amid the pandemic-led jeopardized economy, the Consumer Staples space has been a relatively safe spot. As the sector houses companies offering essentials like packaged foods and beverages, cleaning products, and household and personal care products, among others, it has been in a good position as demand for such products has been high amid the pandemic-induced stockpiling and increased at-home consumption.
We note that the performance of several consumer staple players (especially packaged food and cleaning material companies) has been benefiting from burgeoning demand owing to the coronavirus-led stock hoarding and elevated stay-at-home trends. Further, the gradual reopening of stores, salons and other businesses along with the lifting of certain curbs since May has brought back operations of a number of companies on track, which were otherwise hurt for a while.
We expect these upsides to be reflected in the performance of many players from the Consumer Staples space this earnings season. Apart from this, companies from this space have been benefiting from contributions from buyouts, product innovation and other brand-building efforts. Further, their stringent saving and restructuring efforts have been helping them tackle cost inflation as well as expenditures related to managing operations amid the COVID-19 crisis.
All said, we have brought focus on some consumer staple stocks, which carry a favorable Zacks Rank and have the potential to beat earnings estimates this reporting cycle. Also, most of these companies have delivered returns of more than 8% in the past three months.
Here’s the Right Way to Pick Them
We used the Zacks Stock Screener to identify five well-ranked consumer staple stocks, which are poised to beat the Zacks Consensus Estimate this earnings season. Our research shows that for stocks with the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), the chances of a positive earnings surprise are as high as 70%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
5 Potential Winners
Nu Skin Enterprises, Inc. (NUS - Free Report) is a provider of premium cosmetics, beauty and personal care products. The stock has a Zacks Rank #1 and an Earnings ESP of +13.74%. The company has delivered an earnings surprise of 13.5%, on average, in the trailing three quarters. Carrying a VGM Score of B, shares of Nu Skin have rallied considerably over the past three months. The Zacks Consensus Estimate for earnings in the to-be-reported quarter is pegged at 59 cents per share. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Clorox Company (CLX - Free Report) has rallied 14.8% in the past three months. The stock, which has a Zacks Rank #2 and an Earnings ESP of +0.67%, is worth betting on. The Zacks Consensus Estimate for earnings in the to-be-reported quarter is pegged at $1.99 per share, suggesting growth of 5.9% from the prior-year quarter’s reported figure. This cleaning and household products company has a trailing four-quarter earnings surprise of 6.6%, on average.
Another worthwhile option is B&G Foods, Inc. (BGS - Free Report) , with a Zacks Rank #2 and an Earnings ESP of +1.56%. The Zacks Consensus Estimate for first-quarter 2020 earnings is pegged at 64 cents per share, suggesting growth of 68.4% from the prior-year period’s reported figure. The company, which produces frozen foods and household products, delivered an earnings surprise of 5.4%, on average, in the trailing four quarters and has a VGM Score of A. Shares of the company have gained 28.3% in the past three months.
Nomad Foods Limited (NOMD - Free Report) , which has gained 9.6% in the past three months, also deserves a mention. The stock has a Zacks Rank #2 and an Earnings ESP of +6.25%. The Zacks Consensus Estimate for first-quarter 2020 earnings is pegged at 32 cents, indicating growth of 6.7% from the year-ago quarter’s reported figure. This frozen food provider has a trailing four-quarter earnings surprise of 10.7%, on average.
Investors can even count on Kellogg Company (K - Free Report) , a ready-to-eat convenience food manufacturer, with a Zacks Rank #2 and an Earnings ESP of +1.08%. The company has a trailing four-quarter earnings surprise of 8.3%, on average, and returned 6.2% in the past three months. The consensus mark for second-quarter earnings is pegged at 93 cents. Kellogg flaunts a VGM Score of A.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
5 Consumer Staple Stocks to Buy With Earnings Beat Potential
Even amid the pandemic-led jeopardized economy, the Consumer Staples space has been a relatively safe spot. As the sector houses companies offering essentials like packaged foods and beverages, cleaning products, and household and personal care products, among others, it has been in a good position as demand for such products has been high amid the pandemic-induced stockpiling and increased at-home consumption.
We note that the performance of several consumer staple players (especially packaged food and cleaning material companies) has been benefiting from burgeoning demand owing to the coronavirus-led stock hoarding and elevated stay-at-home trends. Further, the gradual reopening of stores, salons and other businesses along with the lifting of certain curbs since May has brought back operations of a number of companies on track, which were otherwise hurt for a while.
We expect these upsides to be reflected in the performance of many players from the Consumer Staples space this earnings season. Apart from this, companies from this space have been benefiting from contributions from buyouts, product innovation and other brand-building efforts. Further, their stringent saving and restructuring efforts have been helping them tackle cost inflation as well as expenditures related to managing operations amid the COVID-19 crisis.
All said, we have brought focus on some consumer staple stocks, which carry a favorable Zacks Rank and have the potential to beat earnings estimates this reporting cycle. Also, most of these companies have delivered returns of more than 8% in the past three months.
Here’s the Right Way to Pick Them
We used the Zacks Stock Screener to identify five well-ranked consumer staple stocks, which are poised to beat the Zacks Consensus Estimate this earnings season. Our research shows that for stocks with the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), the chances of a positive earnings surprise are as high as 70%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
5 Potential Winners
Nu Skin Enterprises, Inc. (NUS - Free Report) is a provider of premium cosmetics, beauty and personal care products. The stock has a Zacks Rank #1 and an Earnings ESP of +13.74%. The company has delivered an earnings surprise of 13.5%, on average, in the trailing three quarters. Carrying a VGM Score of B, shares of Nu Skin have rallied considerably over the past three months. The Zacks Consensus Estimate for earnings in the to-be-reported quarter is pegged at 59 cents per share. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Clorox Company (CLX - Free Report) has rallied 14.8% in the past three months. The stock, which has a Zacks Rank #2 and an Earnings ESP of +0.67%, is worth betting on. The Zacks Consensus Estimate for earnings in the to-be-reported quarter is pegged at $1.99 per share, suggesting growth of 5.9% from the prior-year quarter’s reported figure. This cleaning and household products company has a trailing four-quarter earnings surprise of 6.6%, on average.
Another worthwhile option is B&G Foods, Inc. (BGS - Free Report) , with a Zacks Rank #2 and an Earnings ESP of +1.56%. The Zacks Consensus Estimate for first-quarter 2020 earnings is pegged at 64 cents per share, suggesting growth of 68.4% from the prior-year period’s reported figure. The company, which produces frozen foods and household products, delivered an earnings surprise of 5.4%, on average, in the trailing four quarters and has a VGM Score of A. Shares of the company have gained 28.3% in the past three months.
Nomad Foods Limited (NOMD - Free Report) , which has gained 9.6% in the past three months, also deserves a mention. The stock has a Zacks Rank #2 and an Earnings ESP of +6.25%. The Zacks Consensus Estimate for first-quarter 2020 earnings is pegged at 32 cents, indicating growth of 6.7% from the year-ago quarter’s reported figure. This frozen food provider has a trailing four-quarter earnings surprise of 10.7%, on average.
Investors can even count on Kellogg Company (K - Free Report) , a ready-to-eat convenience food manufacturer, with a Zacks Rank #2 and an Earnings ESP of +1.08%. The company has a trailing four-quarter earnings surprise of 8.3%, on average, and returned 6.2% in the past three months. The consensus mark for second-quarter earnings is pegged at 93 cents. Kellogg flaunts a VGM Score of A.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>